Magdalena Koss

Magdalena Koss

Auto-generated profile, based on publicly available information

Magdalena Koss

Stefan Kardynał Wyszyński Province Specialist Hospital, Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMagdalena Koss
Magdalena Koss
WZWeronika Ziomek
Weronika Ziomek
EBElżbieta Bebrysz
Elżbieta Bebrysz
JPJan Palmi
Jan Palmi
KDKarolina Dębek
Karolina Dębek
ADAleksandra Drabik
Aleksandra Drabik
Background: Endometriosis is an estrogen-dependent chronic inflammatory disease characterized by the presence of active endometrium outside the uterine cavity, most commonly in the pelvis. It affects an estimated 10-15% of women of childbearing age and is often associated with infertility, chronic pelvic pain, painful menstruation, and dyspareunia. Despite its high prevalence and significant impact on quality of life, the cause of endometriosis remains unclear, and the available treatment methods have many limitations. Aim: This article aims to review current developments in endometriosis treatment, with a focus on new therapeutic strategies involving targeted therapies, nanoparticles and stem cells. Methods: An analysis of the latest (2015-2025) literature from databases such as PubMed and Google Scholar was conducted to synthesize the available information. Search terms included combinations of “Endometriosis treatment,” “pathogenesis of Endometriosis,” “an update on Endometriosis,” “new therapeutics in Endometriosis,” and “immunotherapy in Endometriosis,” “stem cells and the Endometrium.” Results: In recent years, there has been significant progress in developing targeted therapies that modulate specific signaling pathways, hormone receptors, inflammatory cytokines, and angiogenesis within endometrial lesions. Concurrently, the importance of nanotechnology in medicine, particularly in the context of precision drug delivery using nanoparticles, is growing. Additionally, regenerative therapies using stem cells are receiving increasing attention. These therapies offer the potential to repair damaged tissues and modulate the immune response. Conclusion: Although preliminary studies are promising, the introduction of these innovative therapies requires further multi-center studies and evaluation of safety and cost. The integration of targeted therapies, nanotechnology and stem cells along with modern molecular diagnostics may soon revolutionize the treatment of endometriosis. This will pave the way for more effective and less invasive methods to improve patients' quality of life.

25 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
IDIda Dunder
Ida Dunder
MBMateusz Józef Biszewski
Mateusz Józef Biszewski
EBElżbieta Bebrysz
Elżbieta Bebrysz
JPJan Palmi
Jan Palmi
KDKarolina Dębek
Karolina Dębek
WZWeronika Ziomek
Weronika Ziomek
Background: Depression is a widespread mental disorder affecting approximately 280 million people worldwide. While pharmacological treatments and cognitive-behavioral therapy (CBT) are considered first-line interventions, there has been growing interest in recent years in complementary, non-pharmacological therapies, such as Dance Movement Therapy (DMT), which offers a holistic, body-centered approach to improving mental health outcomes. Aim: This review aims to evaluate the current evidence on the effectiveness of Dance Movement Therapy (DMT) in the treatment of depression. It seeks to understand the mechanisms through which DMT exerts its effects and to identify specific populations that may benefit most from this intervention. Methods: A literature review was conducted using PubMed and Google Scholar databases, covering the years 2015 to 2025. Results: DMT has demonstrated positive effects on depressive symptoms across various populations. Improvements were noted not only in mood but also in cognitive functioning, physical health, interpersonal relationships, and emotional regulation. While effect sizes varied, consistent within-group improvements and high adherence rates were observed. Conclusion: DMT is a safe, engaging, and potentially effective adjunctive treatment for depression, especially when personalized and delivered by trained professionals. Its multicausal mechanism of action makes it a valuable tool in the integrative treatment of depressive disorders. Further high-quality, randomized studies are needed to establish standardized clinical guidelines.

23 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ADAleksandra Drabik
Aleksandra Drabik
EBElżbieta Bebrysz
Elżbieta Bebrysz
IDIda Dunder
Ida Dunder
MKMagdalena Koss
Magdalena Koss
MBMateusz Józef Biszewski
Mateusz Józef Biszewski
WZWeronika Ziomek
Weronika Ziomek
Background: Dengue is a global threat expanding its geographic reach and spreading to a growing world population. Up to 3 billion people are at risk. Dengue virus infection can be asymptomatic or sparse, but can also cause dengue hemorrhagic fever and dengue shock syndrome. Aim: The purpose of this article is to highlight the challenges of effective treatment, multi-pronged prevention and safe immunoprophylaxis of dengue virus. Methods: A review of scientific articles published on PubMed and Google Scholar from 2020 to 2025. Results: Due to the number and complexity of dengue serotypes, as well as the antibody-dependent amplification mechanism characteristic of this virus, creating a universal, effective and safe vaccine is a difficult task. It is all the more important because of the lack of specific treatment, which is so necessary in the case of a severe course of the disease in the form of hemorrhagic fever or shock syndrome. It is also necessary to control vectors through chemical, biological and environmental methods. Conclusion: Dengue is now a serious global public health threat that requires urgent action. Key areas for further research and development include a better understanding of pathogenesis, especially in the context of symptomatic DENV infections, and increased work on a variety of treatment and control options, as well as the development of a universal, safe and effective vaccine. The ultimate goal is to reduce the threat of the disease worldwide.

22 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WZWeronika Ziomek
Weronika Ziomek
MKMagdalena Koss
Magdalena Koss
KUKatarzyna Urbańska
Katarzyna Urbańska
AHAnna Hawryluk
Anna Hawryluk
MKMaciej Kwieciński
Maciej Kwieciński
WBWeronika Bomba
Weronika Bomba
Introduction and Objective: Rhabdomyosarcoma (RMS) is the third most common solid and extracranial malignant tumour in children. It originates from mesenchymal tissue and is a heterogeneous tumour in terms of location, histology, clinical presentation and prognosis. The aim of this paper is to provide a comprehensive review of the current state of knowledge on this disease. Description of The State of Knowledge: The total incidence rate of RMS is approximately 4.5 patients per million people under the age of 20. The tumour is most commonly located in the head and neck, less frequently in the urinary tract, limbs and trunk. Histologically, the embryonal type is the most common, accounting for 60-80% of all RMS cases. The symptoms of the disease depend primarily on the location of the primary tumour and may include exophthalmos, visual disturbances, pain and tissue swelling, nosebleeds, haematuria, visible tumours and general symptoms in advanced forms, i.e. weakness, fever and weight loss. One of the key factors influencing the prognosis is the presence of distant cancer metastases. Summary: The diagnosis of RMS is difficult due to the rare occurrence of the disease and non-specific symptoms. Although the cure rate for local disease is generally > 70% of patients, metastatic disease is still associated with low overall survival despite intensive treatment strategies. Therefore, early diagnosis of the disease is very important for achieving the best possible treatment outcomes and full recovery.

19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
EBElżbieta Bebrysz
Elżbieta Bebrysz
JPJan Palmi
Jan Palmi
KDKarolina Dębek
Karolina Dębek
PBPiotr Bartnik
Piotr Bartnik
JBJarosław Baran
Jarosław Baran
WZWeronika Ziomek
Weronika Ziomek
Introduction and purpose: Regenerative medicine has introduced new biological strategies to improve ovarian function in women with diminished ovarian reserve (DOR) or premature ovarian insufficiency (POI). Among them, platelet-rich plasma (PRP) - a concentrate of platelets derived from the patient’s own blood - has gained interest for its potential to stimulate follicular growth and enhance reproductive capacity. PRP contains various growth factors and cytokines that promote angiogenesis, cell proliferation, and tissue repair. This review summarizes current evidence regarding PRP’s mechanisms of action, clinical effects, and safety in the context of ovarian rejuvenation. State of knowledge: PRP is obtained by centrifuging autologous blood to increase platelet concentration, followed by activation using agents such as calcium chloride or thrombin. Once activated, platelets release growth factors including PDGF, VEGF, EGF, IGF, and TGF-β, which are involved in tissue regeneration and modulation of inflammation. When injected into the ovaries, PRP may stimulate dormant follicles, improve blood flow, and alter the ovarian microenvironment via anti-inflammatory and immunomodulatory effects. Early clinical studies report encouraging outcomes such as improved ovarian reserve markers and pregnancy rates. Conclusions: PRP therapy is a promising, minimally invasive technique with potential to support ovarian function in selected patients with POI or DOR. Its use is biologically justified by the regenerative properties of platelet-derived factors. Nevertheless, due to limited and low-quality evidence, as well as a lack of standardized preparation and administration protocols, PRP cannot yet be recommended as routine treatment.

25 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JPJan Palmi
Jan Palmi
EBElżbieta Bebrysz
Elżbieta Bebrysz
KDKarolina Dębek
Karolina Dębek
PBPiotr Bartnik
Piotr Bartnik
JBJarosław Baran
Jarosław Baran
WZWeronika Ziomek
Weronika Ziomek
Background: Acute appendicitis during pregnancy is one of the most common non-obstetric surgical conditions in pregnant women. However, due to the ambiguous symptoms that may be presented, an accurate diagnosis can be delayed or misinterpreted as a result of pregnancy-related changes. Aim: The aim of this article is to highlight the challenges involved in diagnosing and treating acute appendicitis in pregnant women. Methods: A review of scientific articles published on Google Scholar and PubMed from 2015 to 2025. Results: Acute appendicitis in pregnancy presents with identical symptoms or mimics several other diseases, not only obstetric conditions. Surgical treatment is recommended, but there are no clear guidelines favoring either laparoscopic or open methods. Magnetic resonance imaging (MRI) is the most accurate imaging modality for diagnosing acute appendicitis. Laboratory diagnostics do not provide definitive evidence for appendicitis in pregnancy. Conclusion: It is essential to be aware of the numerous ways acute appendicitis can present in pregnancy and to remain critical of an initially proposed diagnosis. The choice of surgical treatment largely depends on the experience and skill of the physician. Therefore, continuous education is necessary to understand the challenges associated with this condition.